ClinicalTrials.govpublic full text
Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.
advanced triple-negative breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 329526
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.